Author
@YYDSxjm YYDSxjm
grade Bx.com/YYDSxjm ↗
Perma-bull deep-diver on shorted micro-cap space, biotech and AI moonshots
Writes long-form, ticker-specific bullish theses and accumul
trader score
+0.19
hit rate
50%
mean α
+0.24%
signals 14d
80
Grade = how their written analysis reads (A best). Trader score = how their last-20 timestamped calls performed vs SPY.
Their picks, scored
Across their last 20 scored bets: 50% hit rate, +0.24% mean alpha, trader score +0.19. Their last-14d mentions, direction-adjusted, have moved +3.3% since posting (mean over 70 mentions with price data).
Recent signals15receipts included
| date (PT) | ticker | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|---|
| 2026-07-02 | SMCI | @YYDSxjm | +0.45 | Hopes SMCI reaches 30 before the July 4 weekend, a bullish target without trade action. | — | tweet ↗ |
| 2026-07-02 | NWBO | @YYDSxjm | +0.65 | Strongly praises DCVax-L plus PolyICLC results and says it should be available to patients. | — | tweet ↗ |
| 2026-07-02 | LITE | @YYDSxjm | +0.20 | Long bull thesis for GRRR as sovereign AI infrastructure platform with revenue growth and $40-$50 framework. | — | tweet ↗ |
| 2026-07-02 | AAOI | @YYDSxjm | +0.20 | Long bull thesis for GRRR as sovereign AI infrastructure platform with revenue growth and $40-$50 framework. | — | tweet ↗ |
| 2026-07-02 | GRRR | @YYDSxjm | +0.85 | Long bull thesis for GRRR as sovereign AI infrastructure platform with revenue growth and $40-$50 framework. | — | tweet ↗ |
| 2026-07-02 | COHR | @YYDSxjm | +0.20 | Long bull thesis for GRRR as sovereign AI infrastructure platform with revenue growth and $40-$50 framework. | — | tweet ↗ |
| 2026-07-01 | BB | @YYDSxjm | +0.75 | Explicitly says Bullish on BB, defending longs and QNX narrative. | -10.1% | tweet ↗ |
| 2026-07-01 | ASTS | @YYDSxjm | +0.75 | Says ASTS story is in infancy and expects gbps and AI satellite power generation in five years. | -1.1% | tweet ↗ |
| 2026-07-01 | ASTS | @YYDSxjm | +0.70 | Details T-Mobile/Grain spectrum sale and expected lease implications for ASTS D2D capacity. | -1.1% | tweet ↗ |
| 2026-07-01 | AIFU | @YYDSxjm | +0.45 | Would love to see AIFU cross 60 before the long weekend. | · | tweet ↗ |
| 2026-07-01 | NIO | @YYDSxjm | +0.35 | Acknowledges NIO missed delivery guidance but emphasizes strong YoY delivery growth and future margins. | -3.6% | tweet ↗ |
| 2026-07-01 | IBRX | @YYDSxjm | +0.65 | Bullish take on ImmunityBio Japan BCG agreement and expected July global expansion news. | +2.6% | tweet ↗ |
| 2026-07-01 | SLS | @YYDSxjm | +0.75 | Says once SLS flies and FDA approves, it will not come back down. | +12.9% | tweet ↗ |
| 2026-07-01 | GME | @YYDSxjm | +0.00 | Says once SLS flies and FDA approves, it will not come back down. | +0.8% | tweet ↗ |
| 2026-06-30 | ASTS | @YYDSxjm | +0.70 | Urges holders not to sell ASTS due to 87M shares short and squeeze dynamics. | -4.2% | tweet ↗ |
Grade is our human read-worthiness rating; trader score is a rolling 20-bet hit-rate/alpha composite — different things, often disagreeing. “Since then” is direction-unaware in the table; the summary line above adjusts for which way they leaned.